Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
{{output}}
Several peptide dual agonists of the human glucagon receptor (GCGR) and the glucagon-like peptide-1 receptor (GLP-1R) are in development for the treatment of type 2 diabetes, obesity and their associated complications. Candidates must have high potency at both... ...
